The Clorox Company (NYSE:CLX) Shares Purchased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. grew its stake in shares of The Clorox Company (NYSE:CLX) by 2.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 307,649 shares of the company’s stock after buying an additional 6,008 shares during the period. Sumitomo Mitsui Trust Group Inc. owned 0.25% of Clorox worth $50,119,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in CLX. Innealta Capital LLC acquired a new position in Clorox in the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC raised its position in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the last quarter. First Foundation Advisors purchased a new position in shares of Clorox during the first quarter valued at approximately $31,000. Family Firm Inc. acquired a new stake in Clorox during the second quarter worth approximately $31,000. Finally, Quarry LP grew its stake in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.57% of the company’s stock.

Clorox Price Performance

CLX stock opened at $167.69 on Friday. The stock has a 50-day simple moving average of $162.39 and a 200-day simple moving average of $147.34. The firm has a market cap of $20.76 billion, a P/E ratio of 58.07, a price-to-earnings-growth ratio of 3.06 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $169.09.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. The business’s quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.49 earnings per share. On average, equities analysts predict that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were given a $1.22 dividend. The ex-dividend date was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 2.91%. Clorox’s payout ratio is currently 170.04%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on CLX shares. Deutsche Bank Aktiengesellschaft raised their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Barclays lifted their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and increased their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, DA Davidson increased their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.